Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Garber

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
The Journal of Biological Chemistry|November 23, 2006
ApoA-I mimetic peptides with differing ability to inhibit atherosclerosis also exhibit differences in their interactions with membrane bilayersShaila P Handattu, David W Garber, Dawn C Horn, et al.
Journal of Lipid Research|September 16, 2010
Oral administration of L-mR18L, a single domain cationic amphipathic helical peptide, inhibits lesion formation in ApoE null miceShaila P Handattu, Geeta Datta, Richard M Epand, et al.
Circulation Research|July 9, 2005
Inhibition of lipopolysaccharide-induced inflammatory responses by an apolipoprotein AI mimetic peptideHimanshu Gupta, Lijun Dai, Geeta Datta, et al.
Current Eye Research|October 4, 2017
ApoA-I Mimetic Peptide 4F Reduces Age-Related Lipid Deposition in Murine Bruch's Membrane and Causes Its Structural RemodelingMartin Rudolf, Armin Mir Mohi Sefat, Yoko Miura, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 18, 2005
An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null miceMohamad Navab, G M Anantharamaiah, Srinivasa T Reddy, et al.
Current Opinion in Lipidology|May 9, 2006
Synthetic peptides: managing lipid disordersGm Anantharamaiah, Mohamad Navab, Srinivasa T Reddy, et al.
The Journal of Biological Chemistry|April 13, 2004
Aromatic residue position on the nonpolar face of class a amphipathic helical peptides determines biological activityGeeta Datta, Raquel F Epand, Richard M Epand, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
The Journal of Biological Chemistry|November 23, 2006
ApoA-I mimetic peptides with differing ability to inhibit atherosclerosis also exhibit differences in their interactions with membrane bilayersShaila P Handattu, David W Garber, Dawn C Horn, et al.
Journal of Lipid Research|September 16, 2010
Oral administration of L-mR18L, a single domain cationic amphipathic helical peptide, inhibits lesion formation in ApoE null miceShaila P Handattu, Geeta Datta, Richard M Epand, et al.
Circulation Research|July 9, 2005
Inhibition of lipopolysaccharide-induced inflammatory responses by an apolipoprotein AI mimetic peptideHimanshu Gupta, Lijun Dai, Geeta Datta, et al.
Current Eye Research|October 4, 2017
ApoA-I Mimetic Peptide 4F Reduces Age-Related Lipid Deposition in Murine Bruch's Membrane and Causes Its Structural RemodelingMartin Rudolf, Armin Mir Mohi Sefat, Yoko Miura, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|June 18, 2005
An oral apoJ peptide renders HDL antiinflammatory in mice and monkeys and dramatically reduces atherosclerosis in apolipoprotein E-null miceMohamad Navab, G M Anantharamaiah, Srinivasa T Reddy, et al.
Current Opinion in Lipidology|May 9, 2006
Synthetic peptides: managing lipid disordersGm Anantharamaiah, Mohamad Navab, Srinivasa T Reddy, et al.
The Journal of Biological Chemistry|April 13, 2004
Aromatic residue position on the nonpolar face of class a amphipathic helical peptides determines biological activityGeeta Datta, Raquel F Epand, Richard M Epand, et al.
Pageof 4